Pedro Silva Cunha
23623
18. EMA ‑ European Medicines Agency recommends measures to reduce risk of heart problems
with Corlentor/Procoralan (ivabradine).
library/Press_release/2014/11/WC500177591.pdf
19. Katz AM. Pharmacology and mechanisms of action of calcium‑channel blockers. J Clin
Hypertens. 1986;2(3 Suppl):28S‑37S.
20. Mancia G, Fagard R, Narkiewicz K, et. al. 2013 ESH/ESC Guidelines for the management of
arterial hypertension. Eur Heart J. 2013;34:2159‑219
21. Fagard RH,Celis H,Thijs L,et al.Regression of left ventricular mass by antihypertensive treatment:
a meta‑analysis of randomized comparative studies. Hypertension. 2009;54:1084–1091.
